Cosmetic claims in the European Union are not merely marketing tools; they are regulated commercial statements subject to legally binding common criteria. Under Regulation (EC) No 1223/2009, cosmetic products compliance extends beyond formulation and safety assessment to include how a cosmetic product is presented and communicated to consumers. All claims must meet the criteria established under Commission Regulation (EU) No 655/2013, ensuring they are truthful, substantiated, fair, and not misleading. Given the regulatory scrutiny across EU Member States, claim substantiation is a critical component of cosmetic compliance strategy, with direct implications for market access and product classification.
Legal Framework Governing Cosmetic Claims in the EU
Cosmetic claims in the European Union are regulated through a combination of horizontal and sector-specific legislation. Article 20 of Regulation (EC) No 1223/2009 establishes that product claims must not attribute characteristics or functions that the cosmetic product does not possess. This requirement applies to all forms of communication, including packaging, labeling, advertising, digital content, and implied claims.
The commission also adopted the Regulation (EU) No 655/2013, which defines six legally binding common criteria:
Legal compliance
Truthfulness
Evidential support
Honesty
Fairness
Informed decision-making
Claim Substantiation: What Evidence Is Expected?
The level and type of substantiation required depend on the nature of the claim, the target audience, and the product’s intended use. Acceptable evidence may include:
Well-designed clinical studies
Instrumental measurements
In vitro or ex vivo studies
Scientifically justified ingredient data
Consumer perception studies, where relevant
Stability or performance testing, depending on the claim
The evidence must be proportionate to the claim made. Importantly, all supporting documentation must be maintained within the Product Information File (PIF), ensuring that substantiation is readily available for competent authorities during market surveillance. In practice, robust claim evaluation requires scientific interpretation, not merely possession of data.
Borderline & High-Risk Claims
Certain claims carry a higher risk of non-compliance because they may:
Blur Cosmetic vs. Medicinal Boundaries:
Statements like “treats acne, “" anti-inflammatory effect, or “repairs DNA” can trigger medicinal product classification.
Overstate Performance:
Claims suggesting exceptional results without robust evidence, e.g., “reduces wrinkles by 30% in 4 weeks”, are highly scrutinized.
Imply Superiority or Comparative Advantage:
“Better than X” or “100% safe” must be substantiated and cannot discredit legally permitted ingredients.
Include “Free-From” Claims:
“Chemical-free”, “paraben-free” claims require careful scientific support.
Use Before-and-After or Visual Comparisons:
Must reflect the finished product, target population, and real conditions of use.
In short, any claim suggesting medical benefit, exceptional efficacy, or environmental superiority is a high-risk statement. Brands and Responsible Persons must rigorously evaluate and document such claims, considering not only the explicit wording but also the overall product presentation to mitigate regulatory, commercial, and reputational risks.
Consequences of Non-Compliance
Non-compliant cosmetic claims can have serious regulatory, commercial, and reputational consequences. Key risks include:
Market Withdrawal: Authorities may recall or remove products from sale.
Corrective Actions: Labels, marketing materials, or online content may need urgent revision.
Reputational Damage: Loss of consumer trust and negative publicity can affect brand credibility long-term.
Legal Liability: Misleading claims can trigger consumer complaints or civil litigation.
Public Enforcement Notices: Non-compliance may be published in RAPEX or national alerts, drawing public attention.
Common Compliance Mistakes:
Copying competitors’ claims without reviewing substantiation or relevance to the finished product.
Using global marketing language that conflicts with EU regulations.
Failing to document internal reasoning or risk assessment behind claims.
Over-relying on raw material supplier data without independent evaluation of the final formulation.
Ignoring borderline medicinal implications, particularly for performance or health-related statements.
Even minor exaggerations or insufficient evidence can trigger enforcement. Proactive claim evaluation and rigorous documentation are essential to prevent regulatory, financial, and reputational harm.
Practical Compliance Strategy for Brands
To minimize regulatory risk and ensure claims are robust, brands should adopt a structured, evidence-based approach:
Early claims strategy alignment during product development
Scientific Substantiation and Internal Documentation
Independent Assessment by avoiding over-reliance on supplier data
Identification of borderline wording
Harmonization between regulation and marketing language
Periodic Review
Expert Consultation
For U.S. brands entering Europe, adapting claims to EU regulatory expectations is especially critical. Marketing language that is acceptable in one jurisdiction may trigger enforcement in another.
Conclusion
Cosmetic claims in the European Union are governed by strict regulatory principles under Cosmetics Regulation (EC) No 1223/2009 and Claims Regulation 655/2013. Every statement made about a product must be truthful, supported by evidence, and aligned with cosmetic classification rules. For brands operating internationally, particularly U.S. companies expanding into the EU, understanding these requirements early prevents costly missteps.
Scientific substantiation and structured regulatory review are no longer optional; they are foundational to responsible cosmetic commercialization in Europe.
FAQs – Cosmetic Claims Compliance in the EU
What is considered a cosmetic claim under EU law?
A claim is any statement, visual, symbol, or message that can influence a consumer’s purchasing decision. This includes labels, packaging, product names, websites, social media, and influencer marketing.
Which EU regulations govern cosmetic claims?
Claims are regulated primarily under Regulation (EC) No 1223/2009 (Article 20) and Commission Regulation (EU) No 655/2013, which set out the six common criteria for claims.
Can social media or influencer posts trigger compliance issues?
Yes. Any post that suggests product benefits or influences purchasing decisions is considered a claim and must comply with EU regulations.
Do environmental or green claims require evidence?
Yes. Claims such as “chemical-free” or “non-toxic” must be scientifically supported and cannot mislead consumers.
Is clinical testing required for all cosmetic claims?
No. Clinical testing is not mandatory for every claim. The required level of substantiation depends on the type and strength of the claim — simple descriptive claims may be supported by literature or instrumental evidence.